Načítá se...
Autologous Lymphapheresis for the Production of Chimeric Antigen Receptor (CAR) T Cells
BACKGROUND: Chimeric antigen receptor (CAR) T cells are a promising new immunotherapy. The first step in manufacturing is to collect autologous CD3+ lymphocytes by apheresis. Patients, however, are often leukopenic or have other disease-related complications. We evaluated the feasibility of collecti...
Uloženo v:
| Vydáno v: | Transfusion |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5398918/ https://ncbi.nlm.nih.gov/pubmed/28236305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.14003 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|